A Clinical Trial Testing the Safety of Pumitamig (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer | MicrobiomeTrials
A Clinical Trial Testing the Safety of Pumitamig (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2025-12-04Est. Completion: 2027-12
Enrollment target: 105 participants
Locations
Flinder's Medical Centre, Bedford Park, Australia
Pindara Private Hospital, Benowa, Australia
Peninsula & South Eastern Haematology and Oncology Group, Frankston, Australia
The Alfred Hospital, Melbourne, Australia
St Vincent's Hospital, Melbourne, Australia
One Clinical Research, Mount Pleasant, Australia
GenesisCare, Saint Leonards, Australia
Sunshine Coast Private Hospital, Sunshine Coast, Australia
Westmead Hospital, Sydney, Australia
Tsinghua Changgung Hospital, Beijing, China
Jilin Cancer Hospital, Changchun, China
Sichuan Cancer Hospital, Chengdu, China
Zhongshan Hospital Affiliated with Dalian University, Dalian, China
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
Zhejiang Provincial People's Hospital, Hangzhou, China
Shandong University Cancer Hospital, Jinan, China
Yunnan Cancer Hospital, Kunming, China
The First Affiliated Hospital of Nanchang University, Nanchang, China
Other microbiome trials you might be interested in
Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)Non-small Cell Lung Cancer (NSCLC)HR+/HER2- Ductal Breast Cancer (BC)HR+/HER2- Lobular Breast Cancer (BC)Triple Negative Breast Cancer (TNBC)Colorectal Cancer (CRC)Soft Tissue Sarcoma (STS)
The purpose of Part 1 of this study is to evaluate the imaging characteristics, safety, biodistribution and pharmacokine…